|
Volumn 17, Issue 3, 2011, Pages 253-254
|
A siege of hepatitis: Fighting a defiant virus
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIVIRUS AGENT;
INTERFERON;
NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR;
NONSTRUCTURAL PROTEIN 5A INHIBITOR;
NUCLEOSIDE ANALOG;
PLACEBO;
PROTEINASE INHIBITOR;
RIBAVIRIN;
RNA DIRECTED RNA POLYMERASE INHIBITOR;
TELAPREVIR;
UNCLASSIFIED DRUG;
ANTIVIRAL RESISTANCE;
ANTIVIRAL THERAPY;
ARTICLE;
DOSE RESPONSE;
DRUG COST;
DRUG EFFICACY;
DRUG RESPONSE;
DRUG TREATMENT FAILURE;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
MONOTHERAPY;
PRIORITY JOURNAL;
UNSPECIFIED SIDE EFFECT;
VIRUS MUTATION;
VIRUS REPLICATION;
ANTIVIRAL AGENTS;
DRUG COSTS;
HEPATITIS VIRUSES;
HEPATITIS, VIRAL, HUMAN;
HUMANS;
MUTATION;
VIRAL LOAD;
|
EID: 79952396969
PISSN: 10788956
EISSN: 1546170X
Source Type: Journal
DOI: 10.1038/nm0311-253 Document Type: Article |
Times cited : (4)
|
References (15)
|